Expand PAVM Menu
PAVM MENU

PAVM Latest Press Releases

-- May 13, 2024 --

PAVmed Provides Business Update and First Quarter 2024 Financial Results PRNewswire 8:43 PM
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results PRNewswire 8:00 AM

-- May 9, 2024 --

Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall PRNewswire 7:49 AM

-- May 7, 2024 --

Lucid Diagnostics Closes Series B / B-1 Preferred Stock Offering and Appoints Healthcare Industry Veteran Dennis Matheis to Board of Directors PRNewswire 7:39 AM

-- May 3, 2024 --

PAVmed to Hold a Business Update Conference Call and Webcast on May 14, 2024 PRNewswire 8:35 AM

-- May 2, 2024 --

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 13, 2024 PRNewswire 8:35 AM
Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard Esophageal Precancer Testing PRNewswire 7:49 AM

-- April 30, 2024 --

PAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute PRNewswire 7:35 AM

-- April 29, 2024 --

Lucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month PRNewswire 8:47 AM

-- April 8, 2024 --

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference PRNewswire 8:30 AM

-- March 26, 2024 --

PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results PRNewswire 7:33 PM

-- March 25, 2024 --

Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year 2023 Financial Results PRNewswire 5:30 PM

-- March 21, 2024 --

Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard Esophageal Precancer Testing in a Screening Population PRNewswire 9:30 AM
PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX PRNewswire 8:30 AM

-- March 20, 2024 --

Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference PRNewswire 8:30 AM

-- March 13, 2024 --

PAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024 PRNewswire 8:30 AM

-- March 12, 2024 --

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024 PRNewswire 8:30 AM

-- February 16, 2024 --

Lucid Diagnostics Provides Update Regarding World Trade Center Health Program PRNewswire 5:00 PM

-- February 15, 2024 --

Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck Esophageal Cell Collection Device during Congressional Testimony PRNewswire 7:45 AM

-- February 8, 2024 --

Lucid Diagnostics Executes Contract to Provide EsoGuard Esophageal Precancer Testing as a Covered Benefit for 9/11 Responders and Survivors PRNewswire 7:45 AM